A series of 5-alkyl-4-methyl-2,5-dihydro-1H-pyridazino [4,5-b]indol-1-ones (3) was prepared from 2-acetylindole-2-carboxylic acid by a one-pot reaction (N-alkylation, followed by ring closure with hydrazine). Similarly, various new 5-alkyl-2,3-dihydro-1H-pyridazino[4,5-b]indole-1,4(5H)-diones (6) were obtained by alkylation and subsequent hydrazinolysis of dimethyl indole-2,3-dicarboxylate. A 5-alkyl representative (10) of the 3,5-dihydro-4H-pyridazino [4,5-b]indol-4-one system was made available by two alternative pathways.
Introduction
The pyridazino [4,5-b] indole scaffold, due to its bio-isosterism with β-carboline as well as γ-carboline, has found considerable pharmaceutical interest as the core structure of a wide variety of bio-active compounds. [1] [2] [3] [4] [5] [6] [7] [8] [9] During the past few years, we have investigated the synthesis and biological activity of various new representatives of this "aza-carboline" ring system, mainly focusing on potential antitumor agents. [10] [11] [12] The title ring system now became interesting also in the context of an ongoing program in search of new and selective inhibitors of copper-containing amine oxidases. 13 Based on preliminary structure-activity information, 14 the need arose to prepare a focused compound library of indole-fused pyridazinones and pyridazinediones bearing various alkyl substituents at the indole nitrogen. Despite their simplicity, surprisingly few representatives of this general structure have been known so far. 10, [15] [16] [17] [18] Here, we wish to report on short and convenient methods for the synthesis of such tricyclic compounds.
the sequence can be carried out very conveniently in a one-pot manner and opens a simple and short access to compounds of type 3 which are free of any contamination by 2,5-disubstituted derivatives. 
Scheme 1
For the preparation of a series of 5-alkyl-substituted 1,4-dihydroxypyridazino [4,5-b] indoles (or their oxo tautomers, respectively), an analogous strategy was chosen. Thus, dimethyl indole-2,3-dicarboxylate 21 was first N-alkylated with an excess of the appropriate alkyl iodide (or benzyl bromide or allyl bromide, respectively) in the presence of potassium carbonate in dimethylformamide solution. Here, the intermediate N-alkyl esters 5 were extractively isolated prior to condensation with hydrazine hydrate which then gave the pyridazino-indole derivatives 6a-f in satisfactory yields. 
Scheme 2
From the pyridazinediones (tautomeric dihydroxypyridazines or hydroxypyridazinones, respectively) of type 6, also mono-oxygenated compounds should be easily accessible by a sequence involving transformation of 6 into the corresponding dichloropyridazine, followed by monosubstitution with hydrazine, oxidative dehydrazination, and finally hydrolysis of the remaining chloro function. This approach was successfully exemplified, starting from the Npropyl derivative 6b, as shown in Scheme 3. Heating with phosphorus oxychloride smoothly afforded the dichloro compound 7 in 82% yield. Hydrazinolysis of 7 indeed gave a monohydrazino-monochloro product regioselectively. An analogous transformation of the 5-unsubstituted dichloro congener, leading to a 1-chloro-4-hydrazino compound, had been previously reported by Monge and coworkers. 22 Interestingly, in our case the regioselectivity of this substitution was found to be completely reversed, leading to the 4-chloro-1-hydrazino derivative 8 exclusively. Obviously, steric shielding of the 4-position by the adjacent N-alkyl residue is responsible for the observed preferential attack of the nucleophile at C-1 rather than at C-4 (as in Monge's 5-unsubstituted compound). The position of the newly introduced hydrazino group was firmly established after its replacement by hydrogen (compound 9) which is ideally suited for an NOE experiment, thus proving the close distance between H-9 and this pyridazine H atom. The transformation of 8 into 9 was accomplished by treatment with mercuric oxide in aqueous suspension in analogy to previous protocols. 23, 24 The final hydrolysis step, affording the new pyridazinone 10, succeeded by heating the chloropyridazine in acetic acid. 25 As a more convenient synthesis of 10, which moreover avoids the use of toxic mercuric oxide, we elaborated a sequence starting from N-propylindole-2-carboxylic acid ethyl ester 26 (11) . This compound could be easily formylated at C-3 with Vilsmeier-Haack reagent under the conditions reported for similar substrates. 27 As expected, the formyl ester 12 was found to cyclize smoothly with hydrazine hydrate in ethanolic solution to afford the tricycle 10 in good yield. 
Scheme 3
In conclusion, a variety of new indole-fused pyridazinones and pyridazinediones bearing small to medium-sized alkyl residues at the indole nitrogen were made accessible by short and convenient synthetic pathways. Preliminary in-vitro tests for inhibition of certain amine oxidases showed only weak activity of the new compounds, further screenings for biological activity are in progress.
Experimental Section
General Procedures. Melting points were determined on a Kofler hot-stage microscope. IR spectra (KBr pellets) were recorded on a Perkin-Elmer 1605 FT-IR instrument. bromide was used), and the mixture was stirred at RT in a closed vessel for the time given below. The volatile components were removed under reduced pressure and the residue was taken up in a mixture of hydrazine monohydrate (3 mL, 60 mmol) and EtOH (10 mL). The solution was refluxed for 24 h, then it was poured into ice-water (100 mL), acidified (pH 2-3) and kept in the refrigerator for at least 0.5 h. The precipitate was collected by filtration, washed with water, and dried. Recrystallisation from EtOH gave the products as almost colorless crystals. 5-Benzyl-4-methyl-2,5-dihydro-1H-pyridazino[4,5-b]indol-1-one (3e) 
5-Ethyl

5-Alkyl-2,3-dihydro-1H-pyridazino[4,5-b]indole-1,4(5H)-diones (6). General procedure.
To a solution of dimethyl indole-2,3-dicarboxylate 21 (0.233 g, 1 mmol) in dry DMF (10 mL) was added K 2 CO 3 (0.420 g, 3 mmol) and the appropriate alkyl iodide (25-35 mmol; for 6e: benzyl bromide; for 6f: allyl bromide), and the mixture was stirred at RT in a closed vessel for 120 h. The mixture was poured into water (200 mL) and it was extracted with CH 2 Cl 2 (3 x 50 mL). The combined extracts were dried over Na 2 SO 4 and evaporated, then the residue was taken up in a mixture of hydrazine monohydrate (3 mL, 60 mmol) and EtOH (10 mL). The solution was refluxed for 24 h, then it was poured into ice-water (100 mL), acidified (pH 2-3) and kept in the refrigerator for at least 0.5 h. The precipitate was collected by filtration, washed with water, and dried. Recrystallisation from EtOH gave the products as almost colorless crystals. (6), 143 (7), 121 (6), 95 (13), 81 (46), 69 (100), 68 (17), 67 (17) , 57 (29), 55 (34). , DMSO-d 6 ) δ 153.8, 151.7, 138.8, 130.6, 126.2, 122.1,  121.6, 120.8, 111.2, 111.0, 43.7, 32.3, 19.3 5-Pentyl-2,3-dihydro-1H-pyridazino[4,5-b]indole-1,4(5H)-dione (6d) . A mixture of compound 6b (0.486 g, 2 mmol) and POCl 3 (12 mL, 128 mmol) was heated to 100°C for 4 h. After cooling, the solution was slowly poured onto ice and it was basified with conc. ammonia. The precipitate was collected by filtration, washed with water, and dried to afford 7 as pale yellow crystals (0.459 g, 82%), mp 159°C. Anal. Calcd. C 13 (9) . To a stirred suspension of yellow HgO (0.432 g, 2 mmol) in water (10 mL) was added compound 8 (0.275 g, 1 mmol) in small portions at RT. Stirring was continued for 2 h, then the mixture was extracted several times with AcOEt. The combined extracts were dried over Na 2 SO 4 and evaporated under reduced pressure. The dark oily residue was subjected to column chromatography (AcOEt) to afford 9 (0.073 g, 30%) as a yellow-orange solid, mp 125-126°C, which was used for the following step without further purification. 1 
5-Ethyl-2,3-dihydro-1H-pyridazino[4,5-b]indole-1,4(5H)-dione (6a
5-Propyl-2,3-dihydro-1H-pyridazino[4,5-b]indole-1,4(5H)-dione (6b
5-Butyl-2,3-dihydro-1H-pyridazino[4,5-b]indole-1,4(5H)-dione (6c
